Renal function in the long term after pediatric liver transplantation: is there a need for protocol kidney biopsies?

Kathleen M Campbell1, John C Bucuvalas

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. Kathleen.campbell@cchmc.org

Insights

Posttransplant renal dysfunction is common in pediatric liver transplant recipients. Strategies like calcineurin inhibitor minimization may preserve kidney function, but more research is needed.

Area of Science:

  • Pediatric Nephrology
  • Transplant Medicine
  • Immunology

Background:

  • Improving survival rates in solid organ transplantation necessitate focus on long-term outcomes.
  • Posttransplant renal dysfunction is a significant contributor to morbidity and mortality in pediatric liver transplant recipients.
  • Understanding and managing renal dysfunction is crucial for improving long-term quality of life.

Purpose of the Study:

  • To provide an overview of current understanding and management of posttransplant renal dysfunction in pediatric liver transplant recipients.
  • To identify existing gaps in knowledge regarding renal dysfunction in this population.
  • To review strategies for preserving renal function post-transplant.

Main Methods:

  • Literature review focusing on studies of renal dysfunction following liver transplantation.
  • Analysis of existing data on adult and pediatric populations.
  • Examination of management strategies and outcomes.

Main Results:

  • Literature on renal dysfunction post-liver transplant predominantly features adult data.
  • Pediatric studies are limited by small sample sizes and varied outcome definitions.
  • Posttransplant renal dysfunction is a frequent and significant outcome in both adult and pediatric liver transplant recipients.

Conclusions:

  • Calcineurin inhibitor minimization is a potential strategy for preserving renal function in pediatric liver transplant recipients.
  • Further research is needed to clarify risk factors for renal dysfunction in children.
  • The roles of kidney biopsy and immunosuppression withdrawal in renal preservation require further investigation.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...